1 / 13

SUPRA-NATIONAL REFERENCE LABORATORY NETWORK

SUPRA-NATIONAL REFERENCE LABORATORY NETWORK. DST QA Round 11, 2004 A. Van Deun & F. Portaels. CONDUCT OF ROUND 11. 20 strains, 10 in duplicate: total 30 cultures non-MDR series: R-mono 7 strains from Borstel, 6 from Paris SRL pre-testing 7 Antwerp strains MIC, sequencing

osias
Download Presentation

SUPRA-NATIONAL REFERENCE LABORATORY NETWORK

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. SUPRA-NATIONAL REFERENCE LABORATORY NETWORK DST QA Round 11, 2004 A. Van Deun & F. Portaels

  2. CONDUCT OF ROUND 11 • 20 strains, 10 in duplicate: total 30 cultures • non-MDR series: R-mono • 7 strains from Borstel, 6 from Paris SRL • pre-testing 7 Antwerp strains • MIC, sequencing • exclusion doubtful strains • mass culture from single colony • 0 contamination, 9 growth failures (#3, #9)

  3. LABS AND METHODS, Rd 6 TO 11

  4. JUDICIAL RESULTS OF ROUND 11 • INH • strains: 10 resistant, 10 susc. • cultures: 15 resistant, 15 susc. • agreement: 100% 18 strains 98% 2 strains

  5. JUDICIAL RESULTS OF ROUND 11 • RIFAMPICIN • 10 resistant, 10 susceptible strains • 16 resistant, 14 susceptible cultures • agreement: 100% 19 strains 57% (judicial susc.) 1 strain (#6)

  6. JUDICIAL RESULTS OF ROUND 11 • STREPTOMYCIN • 11 resistant, 9 susceptible strains • 16 resistant, 14 susceptible cultures • agreement: 100% 13 strains 96% 2 strains 91% 1 strain 70% 2 strains (#1, 7) <70% 2 strains (#6, 9)

  7. JUDICIAL RESULTS OF ROUND 11 • ETHAMBUTOL • strains: 5 resistant, 15 susc. • cultures: 7 resistant, 23 susc. • agreement: 100% 9 strains 90-99% 7 strains 87% 1 strain 70-80% 3 strains (#8, 11, 12)

  8. RESULTS OF ROUND 11

  9. RESULTS OF ROUND 11

  10. RIFAMPICIN INTERMEDIATE RESISTANT STRAIN:results by method

  11. COMPARISON PHENO / GENOTYPIC (SEQUENCING) • Results known for 7 Antwerp strains only • Perfect correlation for H and E • Poor correlation for S (rpsL, rrs530, rrs912) • 0/3 resistant have mutation • Perfect correlation for R with exception of the discordant strain • leu533pro mutation • majority finds susceptible

  12. RIFAMPICIN PROBLEM STRAIN MICs

  13. RIFAMPICIN PROBLEM STRAIN: CLINICALLY • #6, judicial HS resistant, 57% R-susceptible • patient from Bujumbura, Burundi • failure of 2EHRZ / 4H3R3 • failure of 2SEHRZ / 1EHRZ / 5E3H3R3

More Related